ESR1 and breast cancer: For instance, Wagner et al. [11] analyzed the overexpression of MutSα complex proteins in oral squamous cell carcinoma, and Nielsen et al. [25] compared PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated, estrogen receptor-positive breast cancer.